S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NBS

NeoStem, Inc. (NBS)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NBS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
07/28/2015	7:20AM	Dow Jones News	Diageo Terminates Heineken Partnership in South Africa	NASDAQ:NBS	Namibia Breweries Ltd.
06/08/2015	3:07PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:NBS	(MM)
06/08/2015	3:05PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NBS	(MM)
06/05/2015	3:21PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
05/29/2015	7:26AM	GlobeNewswire Inc.	NeoStem Announces Plans to Change Name to Caladrius Biosciences Reflecting Transformation Into Immunotherapy Company	NASDAQ:NBS	(MM)
05/29/2015	5:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
05/28/2015	4:15PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:NBS	(MM)
05/27/2015	5:53PM	GlobeNewswire Inc.	NeoStem Prices $25,000,000 Public Offering of Common Stock	NASDAQ:NBS	(MM)
05/27/2015	4:17PM	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:NBS	(MM)
05/27/2015	4:10PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NBS	(MM)
05/27/2015	3:01PM	GlobeNewswire Inc.	NeoStem Announces Proposed Public Offering of Common Stock	NASDAQ:NBS	(MM)
05/26/2015	6:30AM	GlobeNewswire Inc.	NeoStem Announces Dr. Merrick Ross of MD Anderson Cancer Center as Lead Principal Investigator for Pivotal Phase 3 Trial for ...	NASDAQ:NBS	(MM)
05/21/2015	2:03PM	GlobeNewswire Inc.	Turning Cancer Against Itself: Major Grant Advances Pioneering Melanoma Therapy at NeoStem	NASDAQ:NBS	(MM)
05/06/2015	5:08AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NBS	(MM)
05/06/2015	5:01AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NBS	(MM)
05/05/2015	6:30AM	GlobeNewswire Inc.	NeoStem, Inc. Announces 2015 First Quarter Financial Results and Provides Corporate Update	NASDAQ:NBS	(MM)
05/04/2015	6:30AM	GlobeNewswire Inc.	NeoStem to Present at Multiple May and June Conferences	NASDAQ:NBS	(MM)
04/29/2015	3:01PM	GlobeNewswire Inc.	NeoStem Announces First Patient Randomized in Pivotal Phase 3 Melanoma Immunotherapy Clinical Trial	NASDAQ:NBS	(MM)
04/29/2015	7:30AM	PR Newswire (US)	Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma	NASDAQ:NBS	(MM)
04/27/2015	6:30AM	GlobeNewswire Inc.	NeoStem's Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From the European Medicines Agency	NASDAQ:NBS	(MM)
04/20/2015	6:30AM	GlobeNewswire Inc.	NeoStem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma	NASDAQ:NBS	(MM)
04/09/2015	6:30AM	GlobeNewswire Inc.	NeoStem Announces Extension of Study Under Grant From California Institute of Regenerative Medicine (CIRM) to Fund Research o...	NASDAQ:NBS	(MM)
04/06/2015	6:30AM	GlobeNewswire Inc.	NeoStem to Present at Multiple April Conferences	NASDAQ:NBS	(MM)
03/16/2015	5:11AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
03/16/2015	5:00AM	GlobeNewswire Inc.	NeoStem Announces PreSERVE AMI Clinical Trial One-Year Follow-Up Results	NASDAQ:NBS	(MM)
03/12/2015	6:30AM	GlobeNewswire Inc.	NeoStem to Present at Two Upcoming Investor Conferences in March	NASDAQ:NBS	(MM)
03/05/2015	6:30AM	GlobeNewswire Inc.	NeoStem PreSERVE AMI Clinical Trial One-Year Results to be Presented at American College of Cardiology Annual Scientific Sess...	NASDAQ:NBS	(MM)
03/02/2015	3:01PM	GlobeNewswire Inc.	NeoStem, Inc. Announces 2014 Year-End Financial Results and Provides Corporate Update	NASDAQ:NBS	(MM)
01/22/2015	4:09PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)
01/16/2015	3:35PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NBS	(MM)

Showing the most relevant articles for your search:NASDAQ:NBS

1 2 3 4 5 6 7 8 9 10 Next >>

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions